Revolution Medicines has signed a definitive agreement to acquire biopharmaceuti...
CSP will revive the development of AXR-270, a drug that previously demonstrated ...
Atantares plans to use the $13.9m funding for research and development, service ...
Two lots of Lupin’s Tydemy have been recalled due to a decrease in ascorbic acid...
Experts say the Henrietta Lacks settlement puts pressure on the medical establis...
The FDA says an Intas Pharmaceuticals employee used acid to destroy manufacturin...
For almost 44 years, Willie Bell never missed his appointment to check for prost...
The Biden administration is taking a UnitedHealth Group unit to court over its e...
Three physician groups backed by private equity giant Welsh, Carson, Anderson & ...
As Verily aims to get on track, it has hired Andrew Trister, an oncologist and f...
In the latest edition of STAT's Health Tech newsletter: how YC's only health par...
“We believe that every one of our clients and our partners need to be starting t...
EQRx, the once-buzzy, but now dormant biotech company, is being acquired by Revo...
Medicare announced a pilot program aimed at improving dementia care , but it doe...
It seems like every young tech company is vying for a coveted place in the Silic...
The cannabis industry is dramatically scaling back its presence in Washington.
